Search clinical trials for: Hepatocellular Carcinoma HCC

Total 30296 results

Royal Marsden NHS Foundation Trust

Unknown

Oxaliplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients Undergoing Surgery for High-Risk Rectal Cancer (EXPERT-C)

Colorectal Cancer

Spain, United Kingdom, Sweden
National Institute of Cancerología
Instituto Nacional de Enfermedades Respiratorias

Completed

Effect of All-trans Retinoic Acid With Chemotherapy Based in Paclitaxel and Cisplatin as First Line Treatment of Patients With Advanced Non-small Cell Lung Cancer

Non-Small-Cell Lung Carcinoma

Mexico
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function

Breast Cancer | Head and Neck Cancer | Ovarian Cancer | Lung Cancer | Unspecified Adult Solid Tumor, Protocol Specific

United States
Blood Transfusion Centre of Slovenia

Unknown

Modulation of the Immune Response in Patients With Pancreatic Tubular Adenocarcinoma (SYSTHER)

Pancreatic Tubular Adenocarcinoma

Slovenia
Blood Transfusion Centre of Slovenia
University Medical Centre Ljubljana

Unknown

Influence of Gemcitabine Treatment on Immunological and Serological Profile in Patients With Pancreatic Cancer (GEMSTHER)

Pancreatic Tubular Adenocarcinoma

Slovenia
Pfizer

Completed

SU011248 In The Treatment Of Patients With Bevacizumab (Avastin)-Refractory Metastatic Renal Cell Carcinoma

Carcinoma, Renal Cell

United States
University of Medicine and Pharmacy Craiova
Odense University Hospital; University of Bergen; University of Witten/Herdecke; Newcastle-upon-Tyne Hospitals NHS Trust and other collaborators

Completed

Endoscopic Ultrasound Elastography in Pancreatic Masses (EUS-EG)

Pancreatic Adenocarcinoma | Chronic Pancreatitis

United Kingdom, Denmark, Italy, France, Germany, Belgium, Netherlands, Norway, Romania, Spain
University Hospital, Basel, Switzerland
Sanofi; Roche Pharma AG; Swiss National Science Foundation; Swiss Cancer League

Completed

Gemcitabine, Oxaliplatin and Capecitabine for Advanced Pancreatic Carcinoma (GEMOXEL)

Metastatic Pancreatic Cancer | Locally Advanced Pancreatic Cancer

Switzerland
Universidade Cidade de Sao Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo

Completed

Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2)

Cervical Intraepithelial Neoplasia

Brazil
Immutep S.A.S.
Umanis

Completed

IMP321 Plus First-line Paclitaxel in Metastatic Breast Carcinoma

Metastatic Breast Cancer

France
Peking University

Unknown

mFOLFIRI as the Second Line Chemotherapy for Advanced Esophageal Carcinoma After Failure of 1st Line Treatment of Paclitaxel/DDP : a Phase II Single Center Prospective Clinical Trial

Advanced Esophageal Carcinoma

China
Pierre Fabre Medicament
Bristol-Myers Squibb

Completed

Phase III Trial of Vinflunine Plus Best Supportive Care vs. Best Supportive Care in Patients With Transitional Cell Carcinoma (TCC) of the Urothelial Tract

Bladder Cancer | Bladder Neoplasms | Transitional Cell Carcinoma of the Urothelial Tract

Canada
Immutep S.A.S.
Umanis

Completed

IMP321 Phase 1 Trial in Metastatic Renal Cell Carcinoma (MRCC)

Stage IV Renal Cell Carcinoma

France
Cancer Institute and Hospital, Chinese Academy...
China Medical University, China; Changhai Hospital; Fudan University; Peking Union... and other collaborators

Unknown

A Multi-Center, Non-Controlled Clinical Study of Sorafenib Adjuvant Therapy in Advanced Renal-Cell Carcinoma (AGuo)

Renal Cell Carcinoma

China
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Paclitaxel With or Without PSC 833 in Treating Patients With Metastatic Breast Cancer

Breast Cancer

Canada, United States
Taian Cancer Hospital

Unknown

Study of Lobaplatin，5-Fluorouracil and Leucovorin for the Treatment of Esophageal Carcinoma

Esophageal Carcinoma

China
Chang Gung Memorial Hospital
Sinphar Pharmaceutical Co., Ltd

Unknown

Dose-finding Study of Weekly Paclitaxel and Cisplatin in FIGO IB2 and Bulky IIA Cervical Cancer (Chemothreapy)

Cervical Cancer

Taiwan
The First Affiliated Hospital of Guangzhou Medical...

Unknown

Assisted-VATS Sleeve Lobectomy for Non-small Cell Lung Cancer (VATS)

Non-small Cell Lung Cancer

China
National Institute of Cancerología

Unknown

Effect of All-trans Retinoic Acid With Chemotherapy Based on Paclitaxel and Cisplatin As First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer and Expression of RAR-alfa and RAR-beta as Response Biomarker

Non Small Cell Lung Cancer

Mexico
National Science and Technology Development Agency...
Khon Kaen University

Unknown

Calcitriol in Advanced Intrahepatic Cholangiocarcinoma

Advanced Intrahepatic Cholangiocarcinoma

Thailand
Taipei Veterans General Hospital, Taiwan

Completed

UFUR (Tegafur/Uracil) Plus Iressa in Non-small-cell Lung Cancer

Non-Small-Cell Lung Cancer

Taiwan
Sanofi

Terminated

Safety Study of Docetaxel/Cisplatin Induction Therapy Followed by Concurrent Chemoradiotherapy or Concurrent Chemoradiotherapy Followed by Consolidation Docetaxel/Cisplatin in NSCLC Patients

Non-Small-Cell Lung Carcinoma

France
Charite University, Berlin, Germany
Pfizer

Unknown

Exercise for Patients With Renal Cell Cancer Receiving Sunitinib

Renal Cell Carcinoma

Germany
Shahid Beheshti University of Medical Sciences

Completed

Evaluation of Efficacy of Photodynamic Therapy in Basal Cell Carcinoma

Basal Cell Carcinoma
St. Antonius Hospital

Completed

Response to Influenza Virus Vaccination in Patients Immunocompromised Due to Chemotherapy (RIFLUVAC)

Heart Failure | Mamma Carcinoma

Netherlands
Chinese University of Hong Kong

Completed

Surgery or Chemoradiation for Esophageal Cancer

Esophageal Cancers
Royal Marsden NHS Foundation Trust

Completed

Neoadjuvant Epirubicin, Cisplatin and Capecitabine (ECX) Followed by Definitive Chemoradiation With/Without Surgery for Squamous Cell Carcinoma of the Oesophagus

Oesophageal Carcinoma

United Kingdom
Royal Marsden NHS Foundation Trust

Completed

Pre-operative Epirubicin, Cisplatin, and Capecitabine in Patients With Newly Diagnosed Localised Oesophageal Adenocarcinoma

Adenocarcinoma of Oesophagus

United Kingdom
Institut du Cancer de Montpellier - Val d'Aurelle

Unknown

Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal Cancer

Colorectal Cancer | Esophageal Cancer

France
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Erlotinib as 1st Line Treatment in NSCLC Stage IIIB/IV

Non Small Cell Lung Cancer

Greece
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

PS-341 in Treating Patients With Metastatic Kidney Cancer

Kidney Cancer

United States
Institut Paoli-Calmettes

Unknown

Gemcitabine With or Without Sorafenib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Pancreatic Cancer

France
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Docetaxel/Pemetrexed as 1st Line Treatment in Patients With Non Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer

Greece
University of Alabama at Birmingham
GlaxoSmithKline

Terminated

Maximum Tolerated Dose of Lapatinib When Given With Carboplatin for Recurrent Ovarian Cancer

Ovarian Cancer

United States
Huazhong University of Science and Technology
Ministry of Health, China; Hepatic Surgery Clinical Research Centre of Hubei...

Completed

Surgical Treatment of Hilar Cholangiocarcinoma: Minor or Major Liver Resection?

Hepatectomy | Cholangiocarcinoma | Surgical Treatment
Corcept Therapeutics
Institute for the Study of Aging (ISOA)

Terminated

Mifepristone as Adjunctive Therapy in Alzheimer's Disease

Alzheimer's Disease

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer

Kidney Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Prostate Cancer

United States
Eli Lilly and Company

Completed

To Investigate Efficacy and Safety of Pemetrexed as Second or Third Line Therapy in Patients With Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer

Japan
Simcere Pharmaceutical Co., Ltd

Unknown

A Study of Endostar Combined With Chemotherapy Followed by Endostar Maintenance Therapy to Treat Advanced Non-small Cell Lung Cancer (NSCLC) (NSCLC)

Non-small Cell Lung Cancer (NSCLC)

China
Weill Medical College of Cornell University
Pfizer

Completed

Celecoxib, Paclitaxel, and Carboplatin in Treating Patients With Cancer of the Esophagus

Esophageal Cancer

United States
Sanofi

Completed

Efficacy of Chemoradiotherapy After Neoadjuvant Cisplatin and Docetaxel in the Nasopharynx Carcinoma (Tax-Nazo)

Head and Neck Neoplasms

Turkey
Sanofi

Completed

Neoadjuvant Docetaxel Plus Cisplatin and 5-fluorouracil (TPF) Followed by Concomitant Chemoradiotherapy and Chemoradiotherapy Alone in Locally Advanced Squamous Cell Carcinoma of the Head and Neck Patients (SCCHNS)

Head and Neck Neoplasms

Italy
Sanofi

Completed

Efficacy Study of GEMOX Combination and Vinorelbine in NSCL Patients (GON)

Non Small Cell Lung Cancer

France
Sanofi

Completed

Taxotere Combinations as First Line Therapy for Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer.

Non-small Cell Lung Cancer

Italy
Sanofi

Completed

Docetaxel in Squamous Cell Carcinoma of the Head and Neck (TAX + Cisplatin in SCCHN)

Head and Neck Neoplasms
Sanofi

Completed

ADVANCED Phase II Trial of Weekly vs 3 Weekly Docetaxel and Cisplatin Followed by Gemcitabine in Non-small-cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung

Italy
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Cetuximab in Treating Patients With Stage IV Colorectal Cancer

Colorectal Cancer

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck

Head and Neck Cancer | Non-melanomatous Skin Cancer | Carcinoma of Unknown Primary

United States
Taipei Medical University Hospital

Completed

Salvage Therapy With Bevacizumab Plus Docetaxel and Cisplatin for Taiwanese Metastatic Breast Cancer

Metastatic Breast Cancer

Taiwan

Search clinical trials for: Hepatocellular Carcinoma HCC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Georgia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations